CDX1 is an important molecular mediator of Barrett's metaplasia.
The molecular pathogenesis of Barrett's metaplasia (BM) of the esophagus is poorly understood. The change to an intestinal phenotype occurs on a background of esophagitis due to refluxing acid and bile. CDX1, an important regulator of normal intestinal development, was studied as a potential ke...
Príomhchruthaitheoirí: | Wong, N, Wilding, J, Bartlett, S, Liu, Y, Warren, B, Piris, J, Maynard, N, Marshall, R, Bodmer, W |
---|---|
Formáid: | Journal article |
Teanga: | English |
Foilsithe / Cruthaithe: |
2005
|
Míreanna comhchosúla
Míreanna comhchosúla
-
EpCAM and gpA33 are markers of Barrett's metaplasia.
de réir: Wong, N, et al.
Foilsithe / Cruthaithe: (2006) -
Immunohistochemical Expression of CDX2 in Gastroesophageal Junction Biopsies: An Emerging Marker for Early Intestinal Differentiation of Barrett’s Metaplasia
de réir: Twisha Adhikari, et al.
Foilsithe / Cruthaithe: (2022-04-01) -
Barrett’s Esophagus and Intestinal Metaplasia
de réir: Lu Zhang, et al.
Foilsithe / Cruthaithe: (2021-06-01) -
The Role of CDX2 in Intestinal Metaplasia Evaluated Using Immunohistochemistry
Foilsithe / Cruthaithe: (2012-01-01) -
Immunohistochemical study of epithelial-myofibroblast interaction in Barrett metaplasia
de réir: Ochicha O, et al.
Foilsithe / Cruthaithe: (2010-04-01)